Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease - PubMed
Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease
A Ventura et al. Gastroenterology. 1999 Aug.
Abstract
Background & aims: The relationship between celiac disease and many autoimmune disorders has been explained by the sharing of a common genetic factor. In a multicenter national study, we examined the relationship between the prevalence of autoimmune disorders in celiac disease and the duration of exposure to gluten.
Methods: Over a 6-month period, 909 patients with celiac disease (group A; mean age, 16.1 +/- 3.8 years; grouped according to age at diagnosis into three subgroups [group A1, <2 years; group A2, 2-10 years; and group A3, >10 years]), 1268 healthy controls (group B; mean age, 20.8 +/- 4.5 years), and 163 patients with Crohn's disease (group C; mean age, 28.8 +/- 10 years) were evaluated for the presence of autoimmune disorders.
Results: Prevalence of autoimmune disorders in group A was significantly higher than in group B (14% vs. 2.8%; P < 0.000001) but not higher than in group C (12.9%). Prevalence of autoimmune disorders in celiac disease increased with increasing age at diagnosis: 5.1% in group A1, 17% in group A2, and 23.6% in group A3 (P = 0.000001). In group A3, the prevalence of autoimmune disorders was significantly higher than in group C. In a logistic regression model, age at diagnosis was the only significant predictor variable of the odds of developing an autoimmune disorder (r = 0.3; P < 0.000001).
Conclusions: Our data show for the first time that the prevalence of autoimmune disorders in celiac disease is related to the duration of exposure to gluten.
Similar articles
-
Sategna Guidetti C, Solerio E, Scaglione N, Aimo G, Mengozzi G. Sategna Guidetti C, et al. Gut. 2001 Oct;49(4):502-5. doi: 10.1136/gut.49.4.502. Gut. 2001. PMID: 11559646 Free PMC article.
-
Coeliac disease, autoimmune diseases and gluten exposure.
Viljamaa M, Kaukinen K, Huhtala H, Kyrönpalo S, Rasmussen M, Collin P. Viljamaa M, et al. Scand J Gastroenterol. 2005 Apr;40(4):437-43. doi: 10.1080/00365520510012181. Scand J Gastroenterol. 2005. PMID: 16028438
-
Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet.
Cosnes J, Cellier C, Viola S, Colombel JF, Michaud L, Sarles J, Hugot JP, Ginies JL, Dabadie A, Mouterde O, Allez M, Nion-Larmurier I; Groupe D'Etude et de Recherche Sur la Maladie Coeliaque. Cosnes J, et al. Clin Gastroenterol Hepatol. 2008 Jul;6(7):753-8. doi: 10.1016/j.cgh.2007.12.022. Epub 2008 Feb 6. Clin Gastroenterol Hepatol. 2008. PMID: 18255352
-
Autoimmune diseases and celiac disease which came first: genotype or gluten?
Diamanti A, Capriati T, Bizzarri C, Ferretti F, Ancinelli M, Romano F, Perilli A, Laureti F, Locatelli M. Diamanti A, et al. Expert Rev Clin Immunol. 2016;12(1):67-77. doi: 10.1586/1744666X.2016.1095091. Epub 2015 Oct 16. Expert Rev Clin Immunol. 2016. PMID: 26471843 Review.
-
[Epidemiology of celiac disease].
Lamireau T, Clouzeau H. Lamireau T, et al. Pathol Biol (Paris). 2013 Apr;61(2):e1-4. doi: 10.1016/j.patbio.2011.03.005. Epub 2011 May 25. Pathol Biol (Paris). 2013. PMID: 21616605 Review. French.
Cited by
-
Liver involvement in pediatric celiac disease.
Anania C, De Luca E, De Castro G, Chiesa C, Pacifico L. Anania C, et al. World J Gastroenterol. 2015 May 21;21(19):5813-22. doi: 10.3748/wjg.v21.i19.5813. World J Gastroenterol. 2015. PMID: 26019445 Free PMC article. Review.
-
Nodular regenerative hyperplasia and portal hypertension in a patient with coeliac disease.
Biecker E, Fischer HP, Schepke M. Biecker E, et al. Case Rep Gastrointest Med. 2011;2011:938580. doi: 10.1155/2011/938580. Epub 2011 Aug 28. Case Rep Gastrointest Med. 2011. PMID: 22606433 Free PMC article.
-
Immunological comorbity in coeliac disease: associations, risk factors and clinical implications.
Elli L, Bonura A, Garavaglia D, Rulli E, Floriani I, Tagliabue G, Contiero P, Bardella MT. Elli L, et al. J Clin Immunol. 2012 Oct;32(5):984-90. doi: 10.1007/s10875-012-9693-0. Epub 2012 Apr 19. J Clin Immunol. 2012. PMID: 22526595
-
Hajaj H, Elouali A, Hamami A, Babakhouya A, Rkain M. Hajaj H, et al. Cureus. 2024 May 31;16(5):e61468. doi: 10.7759/cureus.61468. eCollection 2024 May. Cureus. 2024. PMID: 38953066 Free PMC article.
-
Stamellou E, Seikrit C, Tang SCW, Boor P, Tesař V, Floege J, Barratt J, Kramann R. Stamellou E, et al. Nat Rev Dis Primers. 2023 Nov 30;9(1):67. doi: 10.1038/s41572-023-00476-9. Nat Rev Dis Primers. 2023. PMID: 38036542 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical